Whiteside TL - Search Results

1

Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.

Yin XY, Donovan-Peluso M, Whiteside TL, Johnson JT, Day R, Herberman RB, Locker J. Yin XY, et al. Among authors: whiteside tl. Genes Chromosomes Cancer. 1991 Nov;3(6):443-54. doi: 10.1002/gcc.2870030606. Genes Chromosomes Cancer. 1991. PMID: 1777414

2

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Shimizu Y, Demetris AJ, Gollin SM, Storto PD, Bedford HM, Altarac S, Iwatsuki S, Herberman RB, Whiteside TL. Shimizu Y, et al. Among authors: whiteside tl. Int J Cancer. 1992 Sep 9;52(2):252-60. doi: 10.1002/ijc.2910520217. Int J Cancer. 1992. PMID: 1355757

3

Immunologic effector cells in head and neck cancer.

Vitolo D, Letessier EM, Johnson JT, Whiteside TL. Vitolo D, et al. Among authors: whiteside tl. J Natl Cancer Inst Monogr. 1992;(13):203-8. J Natl Cancer Inst Monogr. 1992. PMID: 1356393

4

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze MT, Zeh HJ 3rd, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Lotze MT, et al. Among authors: whiteside tl. J Immunother (1991). 1992 Oct;12(3):212-7. doi: 10.1097/00002371-199210000-00015. J Immunother (1991). 1992. PMID: 1359903

5

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M. Weidmann E, et al. Among authors: whiteside tl. Cancer Res. 1992 Nov 1;52(21):5913-20. Cancer Res. 1992. PMID: 1382847

6

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasumura S, Lin WC, Johnson JT, Herberman RB, Azzarone B, Whiteside TL. Weidmann E, et al. Among authors: whiteside tl. Cancer Res. 1992 Nov 1;52(21):5963-70. Cancer Res. 1992. PMID: 1394222

7

Extravasation of antitumor effector cells.

Whiteside TL, Herberman RB. Whiteside TL, et al. Invasion Metastasis. 1992;12(2):128-46. Invasion Metastasis. 1992. PMID: 1399401 Review.

8

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL. Rabinowich H, et al. Among authors: whiteside tl. J Immunol. 1992 Jul 1;149(1):340-9. J Immunol. 1992. PMID: 1535088

9

Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

Whiteside TL, Jost LM, Herberman RB. Whiteside TL, et al. Crit Rev Oncol Hematol. 1992 Jan;12(1):25-47. doi: 10.1016/1040-8428(92)90063-v. Crit Rev Oncol Hematol. 1992. PMID: 1540337 Review. No abstract available.

10

Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Hata K, et al. Among authors: whiteside tl. Hepatology. 1992 May;15(5):816-23. doi: 10.1002/hep.1840150512. Hepatology. 1992. PMID: 1568723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

712 results

Search Page

Filters